Entries by Thomas Gabrielczyk

Artes enters COVID-19 vaccine race

German vaccine developer ARTES Biotechnology GmbH will develop a COVID-19 subunit vaccine based on virus-like particles (VLP), which include two proteins of SARS-CoV-2.